StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis United States by Quarter

United States ($M)

QuarterlyAnnual

Novartis United States: $6,429M in Q3 2026, up 6.5% from a year earlier.

Latest, Q3 2026
6,429
Period ended Sep 30, 2026
Change on a year earlier
+6.5%
6,036 in Q3 2025
History
30 quarters
Since Q2 2019
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| United States | 6 429 | 6 036 | 7 | 7 | 44 | 43”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUnited States ($M)Year on yearSource
Q3 2026Sep 30, 20266,429+6.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20265,954-4.7%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20264,959-13.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20255,334-11.1%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20256,036+11.6%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20256,249+21.4%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 20255,712+24.5%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20246,002+26.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20245,410+16.4%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20245,146+14.4%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20244,588+13.3%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20234,763+12.9%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20234,648+12.9%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20234,498-46.8%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 20234,050-0.8%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20224,218-74.9%Novartis Form 6-K (0001370368-24-000007) ↗

Breakdown

What makes up united States

Cite this data

StockData. (2026). Novartis United States ($M), quarterly Q2 2019–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-us

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.